Abingdon Health (LON:ABDX) Stock Falls 11.6% – Here’s Why

Abingdon Health Plc (LON:ABDX)’s share price dropped 11.6% during mid-day trading on Tuesday. The company traded as low as GBX 9 and last traded at GBX 9.50. Approximately 747,032 shares were traded during mid-day trading, an increase of 216% from the average session volume of 236,039 shares. The stock had previously closed at GBX 10.75.

Abingdon Health Price Performance

The business’s 50-day simple moving average is GBX 10.70 and its 200-day simple moving average is GBX 10.53. The stock has a market cap of £21.48 million, a PE ratio of -10.49 and a beta of 0.13. The company has a quick ratio of 1.96, a current ratio of 1.91 and a debt-to-equity ratio of 15.05.

Abingdon Health (LON:ABDX) last posted its earnings results on Tuesday, October 13th. The company reported GBX (0.51) earnings per share for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.